Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Mon Aug 28 00:00:00 GMT-04:00 2017
Bristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo® (nivolu ...
PDF (389 KB)
Fri Feb 03 00:00:00 GMT-04:00 2017
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive Complete Response Letter from FDA f ...
PDF (47 KB)
Fri Feb 17 00:00:00 GMT-04:00 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in S ...
PDF (190 KB)
Mon Dec 12 00:00:00 GMT-04:00 2016
Daiichi Sankyo and DarwinHealth Announce Strategic Partnership to Deploy a Quantitative Systems Bio ...
PDF (163 KB)
Mon Oct 30 00:00:00 GMT-04:00 2017
Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collab ...
PDF (239 KB)
Thu Apr 27 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibod ...
PDF (177 KB)
Tue Oct 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial ...
PDF (152 KB)
Mon Nov 07 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in Patients with N ...
PDF (367 KB)
Thu Aug 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabal ...
PDF (98 KB)
Tue Aug 01 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation
PDF (167 KB)
Showing 1 - 10 of 39 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...